Evaluating the effectiveness and safety of sodium selenate as a disease modifying treatment for patients with behavioural variant Frontotemporal Dementia (bvFTD)

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Malpas, Charles (Chief Investigator (CI))
  • Velakoulis, Dennis (Chief Investigator (CI))
  • Piguet, Olivier (Chief Investigator (CI))
  • Kalincik, Tomas (Chief Investigator (CI))
  • Walterfang, Mark A. (Chief Investigator (CI))
  • Ahmed, Rebekak (Chief Investigator (CI))
  • Bush, Ashley Ian (Chief Investigator (CI))
  • Darby, David G. (Chief Investigator (CI))
  • Brodtmann, Amy (Chief Investigator (CI))

Project: Research

Project Details

Short titleSodium selanate in patients with bvFTD
Effective start/end date1/04/1931/03/25


  • Department of Health and Aged Care (Australia): A$1,604,184.40